An Analytical Comparison of Dako 28-8 PharmDx Assay and an E1L3N Laboratory-Developed Test in the Immunohistochemical Detection of Programmed Death-Ligand 1.
about
Concordance study of PD-L1 expression in primary and metastatic bladder carcinomas: comparison of four commonly used antibodies and RNA expression.Undifferentiated Pancreatic Carcinomas Display Enrichment for Frequency and Extent of PD-L1 Expression by Tumor Cells.PD-L1 immunohistochemistry for non-small cell lung carcinoma: which strategy should be adopted?STAT3 as a potential immunotherapy biomarker in oncogene-addicted non-small cell lung cancer.Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes.Anti-PD-1/PD-L1 Therapy for Non-Small-Cell Lung Cancer: Toward Personalized Medicine and Combination Strategies
P2860
An Analytical Comparison of Dako 28-8 PharmDx Assay and an E1L3N Laboratory-Developed Test in the Immunohistochemical Detection of Programmed Death-Ligand 1.
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
An Analytical Comparison of Da ...... of Programmed Death-Ligand 1.
@ast
An Analytical Comparison of Da ...... of Programmed Death-Ligand 1.
@en
type
label
An Analytical Comparison of Da ...... of Programmed Death-Ligand 1.
@ast
An Analytical Comparison of Da ...... of Programmed Death-Ligand 1.
@en
prefLabel
An Analytical Comparison of Da ...... of Programmed Death-Ligand 1.
@ast
An Analytical Comparison of Da ...... of Programmed Death-Ligand 1.
@en
P2093
P2860
P1476
An Analytical Comparison of Da ...... of Programmed Death-Ligand 1.
@en
P2093
Diana M Cardona
Gabe Mintier
H David Inzunza
James Novotny
John Cogswell
John N Feder
P2860
P2888
P356
10.1007/S40291-016-0237-9
P577
2016-09-26T00:00:00Z
P6179
1023885390